Yinghao Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yinghao Sun has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Dan Shen
Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
1 shared publicationGuanzhong Liu
Department of Radiology Imaging, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
1 shared publicationHaitao Wang
Department of E.N.T., Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
1 shared publicationHuamao Ye
Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
1 shared publicationJinming Huang
Department of Urologic Surgery, The 85th Hospital of PLA, Shanghai 200052, P.R. China
1 shared publication- Li Jiao
Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
1 shared publication
Latest Publications
- 26 June 2015
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (3) , 1203-1210
HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells
HOXA1, a member of the HOX gene family, has been implicated in tumor progression. However, the role of HOXA1 in prostate cancer is not well-established. In the present study, we found that HOXA1 was highly expressed in prostate cancer cells. We then repressed the expression of HOXA1 by short hairpin RNA (shRNA) to investigate the function of HOXA1 in prostate cancer cells. Our in vitro data showed that knockdown of HOXA1 attenuated the growth, invasion and migration of prostate cancer DU-145 and PC-3 cells. Furthermore, knockdown of HOXA1 resulted in an increased E-cadherin level and decreased Snail and MMP-3 levels in the DU-145 cells. In addition, knockdown of HOXA1 inhibited activation of ERK1/2 and AKT in the DU-145 cells. Our in vivo data revealed that knockdown of HOXA1 suppressed the growth and metastasis of prostate cancer cells. Collectively, our findings suggest that HOXA1 is involved in the regulation of prostate cancer progression, including cell growth, migration, invasion and metastasis. Thus, downregulation of HOXA1 may be a novel approach for the treatment of prostate cancer.
- 26 June 2015
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (3) , 1203-1210
HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells
HOXA1, a member of the HOX gene family, has been implicated in tumor progression. However, the role of HOXA1 in prostate cancer is not well-established. In the present study, we found that HOXA1 was highly expressed in prostate cancer cells. We then repressed the expression of HOXA1 by short hairpin RNA (shRNA) to investigate the function of HOXA1 in prostate cancer cells. Our in vitro data showed that knockdown of HOXA1 attenuated the growth, invasion and migration of prostate cancer DU-145 and PC-3 cells. Furthermore, knockdown of HOXA1 resulted in an increased E-cadherin level and decreased Snail and MMP-3 levels in the DU-145 cells. In addition, knockdown of HOXA1 inhibited activation of ERK1/2 and AKT in the DU-145 cells. Our in vivo data revealed that knockdown of HOXA1 suppressed the growth and metastasis of prostate cancer cells. Collectively, our findings suggest that HOXA1 is involved in the regulation of prostate cancer progression, including cell growth, migration, invasion and metastasis. Thus, downregulation of HOXA1 may be a novel approach for the treatment of prostate cancer.